Patent details

LUC00084 Product Name: Peramivir et ses sels pharmaceutiquement acceptables

Basic Information

Publication number:
LUC00084
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP989660030
Legal Status:
Expired
Application number:
LUC00084
First applicant's nationality:
Procedural language:
French

Marketing Authorization

Marketing Authorization Number:
EU/1/18/1269
Marketing Authorization Type:
Marketing Authorization Date:
17/04/2018
Marketing Authorization Status:
Accepted
Marketing Authorization Country:
Luxembourg (LU)

Dates

Filing date:
22/08/2018
First Marketing Authorization date:
17/04/2018
Grant date:
08/11/2018
Activation date:
17/12/2018
Publication date:
29/08/2018
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
17/12/2023
SPC Extension Expiration:
17/12/2023
Rejection date:
Withdrawal date:

Owner

From:
22/08/2018
 
 

Name:
BIOCRYST PHARMACEUTICALS, INC.
Address:
4505 Emperor Boulevard, Suite 200, Durham, North Carolina 27703, United States (US)

Agent

Name:
Office FREYLINGER S.A.
From:
18/12/2038
Address:
PO Box 48, 8001, STRASSEN, Luxembourg (LU)
To:

Publication

Bulletin

1

Bulletin Heading:
SPC1
Bulletin edition number:
2018/10
Publication date:
19/09/2018
Description:
Section C : Published requests for Supplementary Protection Certificates – I1 publication

2

Bulletin Heading:
SPC2
Bulletin edition number:
2018/13
Publication date:
13/12/2018
Description:
Section D : Granted supplementary protection certificates – I2 publication

3

Bulletin Heading:
SPC3
Bulletin edition number:
2019/01
Publication date:
09/01/2019
Description:
Section E : Supplementary Protection certificates entered into force – IA publication

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
12/12/2022
Last Annual Fee Paid Number:
25
Last Annual Fee Paid Amount:
450 Euro
Payer:
OFFICE FREYLINGER S.A.
Filing date Document type Number of pages
08/11/2018 Certificate 1
22/08/2018 Application Form 4
29/08/2018 Outgoing Correspondence 1
08/11/2018 Publication 1
02/04/2222 General Document 2
22/08/2018 General Document 26
29/08/2018 Publication 1
22/08/2018 General Document 4